Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
| Status: | Archived |
|---|---|
| Conditions: | Cervical Cancer, Cardiology, Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Oncology, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2009 |
| End Date: | August 2011 |
The purpose of this study is to determine if intravitreal infliximab is a safe and effective
treatment for macular edema secondary to uveitis.
Participants with uveitic macular edema will be treated with one injection of intravitreal
infliximab (2.0mg/0.05ml) and followed for three months. Outcomes that be assessed include
best-corrected visual acuity, macular thickness as measured by optical coherence tomography,
and electroretinogram responses.
We found this trial at
1
site
Click here to add this to my saved trials
